Rebuilding the Extracellular Matrix in Wound Healing and Aesthetics

In this episode of The Cutaneous Connection, we sat down with Miles Harrison, president and CEO of Conexeu Sciences, along with the company's chief medical officer, Dr. Brian Pilcher. We spoke about the development of an investigational extracellular matrix -based regenerative platform, CXU, that aims to restore tissue architecture rather than simply replace lost volume. 

In this discussion, the executives explore the science behind the technology, its potential applications in wound healing and medical aesthetics, the growing need for regenerative solutions in the era of GLP-1–associated weight loss, and Conexeu's regulatory strategy as it advances toward clinical translation.